GENEART GmbH Receives Patent for Directed Evolution of Proteins

REGENSBURG, GERMANY -- (MARKET WIRE) -- April 30, 2007 -- GENEART AG, the world's leading specialist in the production and optimization of synthetic genes, announced today that a patent for the directed evolution of proteins has been granted by the German Patent and Trademark Office ("Deutsches Patent- und Markenamt"). A comparable patent application has been submitted in the PCT phase in several countries throughout Europe and Northern America.